glp-1 afib New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib — independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight Effects of Glucagon-Like Peptide-1 Receptor

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

Foods to avoid High-fat foods, particularly fried foods and fatty animal products, significantly worsen GI side effects on tirzepatide

The paper explores the science at the intersection of metabolic hormones and precision nutrition and multi-target therapies, like tirzepatide and retatrutide.

Tirzepatide (Mounjaro and Zepbound), semaglutide-based medications such as Wegovy, and other GLP-1based treatments require medical evaluation to determine eligibility, appropriate dosing, and safety

However, you shouldn't be complacent either